Aesthetic nurse prescriber Anna Baker discusses multi-modality approaches to addressing tissue changes with glucagon-like peptide-1 agonists and glucose-dependent insulinotropic polypeptide therapies Current literature suggests that medical aesthetic practitioners are noticing an increase in demand from patients seeking treatments to counteract …
ICAM reveals data from National Practitioner Audit
January 23, 2026